Its close anatomical relationship to the myocardium and coronary arteries gives epicardial fat potential local effects that broader measures of adiposity may not capture. Because this tissue is metabolically active, changes in its thickness may relate to inflammation near the heart, vascular function, and myocardial performance. This makes the measure relevant to cardiometabolic assessment.
Greater EAT thickness is often associated with obesity and insulin resistance, linking the imaging finding to broader metabolic dysfunction. These associations do not make thickness a standalone diagnosis, but they support its use as a marker for investigating cardiometabolic health. In clinical research, the measure can help examine how visceral fat relates to cardiovascular disease risk.
The tissue’s position beside coronary arteries and the myocardium allows its metabolic activity to be considered in relation to local inflammation, vascular function, and myocardial performance. Consequently, EAT thickness can be studied alongside coronary atherosclerosis and cardiac dysfunction. Its value lies in examining these interconnected processes rather than treating the measurement as an isolated explanation for disease.
EAT thickness can add an imaging-based perspective to cardiometabolic risk assessment because it reflects fat located directly around the heart. Increased measurements are often found in settings associated with higher cardiovascular risk, including obesity and insulin resistance. Clinicians and researchers therefore interpret the measure as one potential risk-related marker, alongside the broader clinical context.
Cardiac imaging is used to assess EAT thickness, with echocardiography identified as a particularly relevant approach. The resulting measurement provides an imaging-based estimate of the fat layer surrounding the heart, allowing clinicians or investigators to examine its relationship with cardiometabolic findings. The procedure supports cardiovascular risk stratification and research into local cardiac and vascular effects.
Clinicians may consider EAT thickness when evaluating cardiometabolic health and cardiovascular risk, especially in research or assessment involving obesity, insulin resistance, coronary atherosclerosis, or cardiac dysfunction. It can contribute to risk stratification by adding information about fat adjacent to cardiac structures. The measurement is best understood as supportive information rather than a replacement for comprehensive evaluation.
Researchers can measure EAT thickness when investigating whether lifestyle or medical interventions are accompanied by changes in cardiometabolic risk. Repeated or comparative imaging assessments may help relate the tissue measurement to changes in cardiovascular status. This application makes the measure useful for studying links between visceral fat around the heart and outcomes involving coronary disease or cardiac function.